Fagron NV's (EBR:FAGR) Popularity With Investors Is Under Threat From Overpricing
Oct 29
Have your own idea? Try our Stock Screener
Belgian (BEL20) Healthcare Sector Analysis
UpdatedNov 02, 2025
DataAggregated Company Financials
Companies13
- 7D-4.4%
- 3M21.1%
- 1Y26.3%
- YTD17.6%
Over the last 7 days, the Healthcare industry has dropped 4.4%, driven by UCB declining 8.5%. Over the past 12 months, the industry was up 26%. Looking forward, earnings are forecast to grow by 23% annually.
Sector Valuation and Performance
Has the Belgian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 02 Nov 2025 | €97.4b | €12.7b | €2.7b | 25.8x | 36.5x | 7.6x |
| Tue, 30 Sep 2025 | €91.6b | €12.2b | €2.4b | 33.4x | 37.7x | 7.5x |
| Thu, 28 Aug 2025 | €85.3b | €12.1b | €2.4b | 34.1x | 35.6x | 7x |
| Sat, 26 Jul 2025 | €73.9b | €11.0b | €1.9b | 36.4x | 38.1x | 6.7x |
| Mon, 23 Jun 2025 | €67.1b | €11.0b | €2.0b | 33.8x | 34.3x | 6.1x |
| Wed, 21 May 2025 | €70.3b | €11.1b | €2.0b | 34.7x | 35.6x | 6.4x |
| Fri, 18 Apr 2025 | €65.2b | €10.7b | €1.8b | 40.1x | 36.7x | 6.1x |
| Sun, 16 Mar 2025 | €76.3b | €10.7b | €1.9b | 43.7x | 40.3x | 7.1x |
| Tue, 11 Feb 2025 | €84.2b | €9.8b | €269.7m | 63.2x | 312.2x | 8.6x |
| Thu, 09 Jan 2025 | €84.6b | €9.8b | €269.7m | 61.6x | 313.7x | 8.7x |
| Sat, 07 Dec 2024 | €79.3b | €9.7b | €270.6m | 60x | 293.1x | 8.2x |
| Mon, 04 Nov 2024 | €76.0b | €9.7b | €282.0m | 60.4x | 269.6x | 7.8x |
| Wed, 02 Oct 2024 | €69.3b | €9.4b | €132.8m | 58x | 521.6x | 7.4x |
| Fri, 30 Aug 2024 | €67.3b | €9.4b | €62.1m | 58.7x | 1084.5x | 7.2x |
| Sun, 28 Jul 2024 | €63.8b | €9.4b | €50.9m | 57.7x | 1251.5x | 6.8x |
| Tue, 25 Jun 2024 | €57.8b | €8.9b | €34.7m | 52.9x | 1664.3x | 6.5x |
| Thu, 23 May 2024 | €51.6b | €8.9b | €37.2m | 49.4x | 1387.6x | 5.8x |
| Sat, 20 Apr 2024 | €49.8b | €8.8b | €58.0m | 46.4x | 858.7x | 5.7x |
| Mon, 18 Mar 2024 | €46.5b | €8.7b | €28.7m | 43.6x | 1622x | 5.4x |
| Wed, 14 Feb 2024 | €45.2b | €9.1b | -€88,442,410.60 | 40.5x | -511.5x | 5x |
| Fri, 12 Jan 2024 | €42.1b | €9.1b | -€124,225,039.00 | 38.8x | -338.8x | 4.6x |
| Sun, 10 Dec 2023 | €45.2b | €9.1b | -€128,952,747.00 | 37x | -350.8x | 5x |
| Tue, 07 Nov 2023 | €45.8b | €9.1b | -€145,474,634.00 | 31.6x | -314.5x | 5x |
| Thu, 05 Oct 2023 | €47.6b | €9.0b | -€305,701,823.00 | 33.8x | -155.8x | 5.3x |
| Sat, 02 Sep 2023 | €49.8b | €9.0b | -€364,541,143.00 | 35.5x | -136.5x | 5.5x |
| Mon, 31 Jul 2023 | €47.7b | €8.9b | -€325,571,831.00 | 40.6x | -146.6x | 5.3x |
| Wed, 28 Jun 2023 | €41.3b | €9.1b | -€348,588,447.00 | 36.2x | -118.5x | 4.5x |
| Fri, 26 May 2023 | €43.4b | €9.1b | -€357,752,143.00 | 38.6x | -121.4x | 4.8x |
| Sun, 23 Apr 2023 | €43.0b | €8.9b | -€266,967,671.00 | 28.8x | -161.1x | 4.8x |
| Tue, 21 Mar 2023 | €39.6b | €8.9b | -€268,909,073.00 | 25.5x | -147.3x | 4.5x |
| Thu, 16 Feb 2023 | €40.4b | €9.1b | €139.2m | 16.1x | 290.4x | 4.5x |
| Sat, 14 Jan 2023 | €42.3b | €9.0b | €127.4m | 15.9x | 331.8x | 4.7x |
| Mon, 12 Dec 2022 | €40.3b | €9.0b | €105.0m | 14.4x | 383.4x | 4.5x |
| Wed, 09 Nov 2022 | €40.8b | €9.0b | €67.1m | 14.5x | 607.6x | 4.5x |
Price to Earnings Ratio
607.6x
Current Industry PE
- Investors are pessimistic on the Belgian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 39.8x which is lower than its 3-year average PE of 234x.
- The 3-year average PS ratio of 6.0x is lower than the industry's current PS ratio of 8.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 232% per year over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare sector?
| BE Market | -1.35% | |
| Healthcare | -4.43% | |
| Biotech | 0.51% | |
| Life Sciences | 0% | 0 |
| Healthcare Services | -0.96% | |
| Healthtech | -1.89% | |
| Medical Equipment | -2.98% | |
| Pharma | -8.31% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 27.0% and investors are willing to pay a premium for that growth.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 103% over the next 5 years.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ARGX argenx | €705.60 | 0.5% +€220.3m | 27.9% | PE32.5x | |
| HYL Hyloris Pharmaceuticals | €5.92 | 9.6% +€14.6m | 2.1% | PS19.6x |
